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Introduction
Accurate measurement of PO2 in biologic tissues has been of
interest to both researchers and clinicians for many years [1].
For basic scientists measurement of PO2 provides insight into
the complexities of oxygen flux at the tissue level, whereas for
clinicians it moves the monitoring window a step closer to the
cell. PO2 monitoring has been exploited most effectively by
radiation oncologists, who have used intratumoral PO2 mea-
surements to plan and guide radiotherapy [2]. Many articles
in the anesthesia and critical care literature report the applica-
tion of different technologies designed to measure tissue PO2
[1,3–14], but the clinical use of PO2 measurement has largely
been limited to assessment of brain tissue [15,16].
Existing technologies for measuring tissue PO2 are either too
expensive for everyday clinical use [14] or are based on
polarographic principles [17], meaning that oxygen is con-
sumed in the measurement process. In time this oxygen con-
sumption affects the signal itself, and this effect persists as
tissue PO2 decreases, perhaps making polarographic devices
less suitable for detection of tissue hypoxia. We hypothesized
that a PO2 measurement technique based on dynamic fluo-
rescence quenching would provide a way to overcome the
limitations of the current polarographic technique. We report
here a head-to-head bench comparison of PO2 measurement
using polarography versus measurement using dynamic fluo-
rescence quenching. We also present preliminary data from
an animal model of tissue ischemia and hypoxia that provide
FiO2=fractional inspired oxygen; PO2=partial oxygen tension.
Abstract
Introduction and methods Dynamic fluorescence quenching is a technique that may overcome some
of the limitations associated with measurement of tissue partial oxygen tension (PO2). We compared
this technique with a polarographic Eppendorf needle electrode method using a saline tonometer in
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between them (r2 = 0.99). The polarographic system exhibited proportional bias that was not evident
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evidence of a potentially useful application of fluorescence
quenching as a monitor of tissue integrity.
Methods
Tonometry apparatus
We constructed an equilibration tonometer (from a sealed,
inverted 50-ml syringe part filled with 0.9% saline and a
length of tubing ending in a diffusing stone) and immersed it
in a water bath maintained at a constant temperature (37°C).
We then connected the tubing to a low pressure oxygen/
nitrogen gas mixer, such that gas bubbled through the stone
and saline solution. A loose cover maintained the gas mixture
above the saline but was not so tight as to cause the pres-
sure to rise above atmospheric pressure. In an earlier experi-
ment we determined that the PO2 in the saline solution
equilibrated within 90 s (unpublished observations). An
oxygen fluorescence quenching probe (FOXY; Ocean Optics
Inc., Dunedin, FL, USA), electronic thermometer, and polaro-
graphic (Eppendorf Instruments, Hamburg, Germany) needle
electrode were inserted through the tonometer cover. The
oxygen concentration of the inflow gas was measured in-line
with a conventional fuel cell oxygen analyzer and this was
used to calculate a predicted PO2 (PO2 pred) in the saline
according to the following equation:
PO2 pred = FiO2 × (PB – PH2O) (1)
Where FiO2 is the oxygen concentration in the inflow gas, PB
is the atmospheric pressure recorded in the laboratory on the
day of the experiment, and PH2O is the water vapor pressure.
Dynamic fluorescence quenching optode
The optode consists of a 200-µm aluminum-coated, ruthenium-
tipped glass fiber with a medical-grade silicone covering on the
tip. The response time of the device is about 45 s in a liquid
medium. The light source is a dedicated light-emitting diode
that emits pure blue light at a wavelength of 470 nm. When
excited the ruthenium emits light (fluoresces) with peak inten-
sity at 600 nm that is quenched by the presence of oxygen. The
fluorescence signal is then converted to a PO2 value by special-
ized software (OOISENSORS; Ocean Optics Inc.).
Polarographic needle electrode
This system has been described in detail elsewhere [18].
Briefly, it comprises a needle electrode mounted on a step-
ping motor that sequentially advances and then retracts the
needle tip. This allows the system to create a histogram of
PO2 recordings from the tissue of interest. The current pro-
duced by the needle electrode is linearly related to the PO2
value in the medium surrounding the electrode tip.
Bench comparison experiment
Calibration
For the fluorescence quenching system we used a 1%
weight/volume solution of sodium sulfite as zero PO2 for the
low calibration standard. This chemical does not affect the
optical sensing system. Sterile water in equilibration with lab-
oratory air was used as a high calibration standard, using
equation 1 with FiO2 set to 0.21. Although it is theoretically
reasonable to calibrate the sensor in one medium (e.g.
gaseous) and then measure PO2 in another (e.g. liquid), we
have no experimental data to support this.
The needle electrode was calibrated according to the manu-
facturer’s instructions [19]. As described above, our labora-
tory bench tonometer was kept at a constant temperature of
37 ± 1°C. It was thus not necessary to correct for tempera-
ture in this experiment.
Measurement protocol
Once both measurement systems had been calibrated and
inserted into the saline tonometer, the system was allowed to
come to equilibrium for 5 min. We then varied the concentra-
tion of oxygen in the inflow gas so that the PO2 in the saline
would rise or fall. After each change, we waited 3 min for the
system to equilibrate before recording the PO2 value from
each device and the PO2 pred value from the inflow gas. We
repeated these steps to record 58 consecutive data triplets.
Finally, we re-measured the low and high calibration solutions




The experimental protocol was approved by The University of
Texas M.D. Anderson Cancer Center Animal Care and Use
Committee. Male outbred Sprague–Dawley rats (n =3 )
weighing 410–440 g were anesthetized using inhaled isoflu-
rane in a mixture of 35% oxygen and 65% nitrogen. Each
animal was placed on a homeothermic blanket (Harvard
Apparatus Inc., Holliston, MA, USA); the trachea was then
intubated (using a modified neonatal laryngoscope and 14-
gauge cannula) and the lungs were mechanically ventilated. A
small midline laparotomy was performed to allow for place-
ment of a vascular clip on the infrarenal aorta. Cannulae (PE
20; Harvard Apparatus Inc.) were placed in the left femoral
artery and vein to allow measurement of arterial pressure
(MLT-1050 transducer; AD Instruments, Mountain View, CA,
USA) and administration of 1 ml/100 g per h 0.9% saline.
Neuromuscular blockade was achieved using 0.2 mg/kg pan-
curonium bromide by intravenous bolus, supplemented later
as needed. Finally, the dynamic fluorescence quenching
optode was attached to a micromanipulator and inserted (via
a 19-gauge needle) percutaneously into the right hind limb
skeletal muscle bed.
Experimental protocol
Once surgery was complete, the animal was allowed to
recover for 20 min before the experiment began. Following an
initial baseline period of 5 min the aorta was cross-clamped
for 30 min, after which the vascular clip was removed. After a
20-min period of reperfusion, the animal was ventilated withCritical Care    February 2001 Vol 6 No 1 Shaw et al.
100% nitrogen for 90 s and then the FiO2 was returned to
0.35. After a further period of ventilation, the animal was killed
by isoflurane overdose and exsanguination via the arterial line.
Data analysis
To identify relationships between the two measurement tech-
niques and PO2 pred, we calculated product–moment correla-
tion statistics. To investigate differences between the two
systems and PO2 pred, we constructed Bland–Altman plots
[20]. For the animal data we performed one-way analysis of
variance with Newman–Keuls post-testing to detect differ-
ences within groups. Analyses were performed in Excel 2000
(Microsoft Inc., Redmond, WA, USA) using the Analyse-It sta-
tistical add-in (Analyse-It Software Ltd, Leeds, UK) and




Fig. 1A shows the changes in PO2 pred, fluorescence quench-
ing PO2, and polarographic PO2 values plotted against time.
There was remarkable agreement between the data gener-
ated by the quenching technique and that generated by the
polarographic technique (r2 = 0.99, P < 0.0001; Fig. 1B), but
this analysis hides a difference that only becomes apparent
on consideration of the Bland–Altman plot of the two mea-
surement techniques (Fig. 1C). Bias proportional to the mag-
nitude of the signal was clearly evident, but it remained
unclear which device was responsible for it. Plots of both
techniques compared with PO2 pred revealed an apparent pro-
portional bias in the polarographic data but not in the quench-
ing data (Figs 2A and 2B). As suggested by Bland and
Altman [20], log transformation (Fig. 2C) shows correction of
the bias in the polarographic plot, suggesting that the error
arose from the polarographic dataset. The fluorescence
quenching system showed minimal drift across the course of
the experiment (low points were 0.0 and 0.08 kPa and high
points were 20.2 and 20.9 kPa at the start and finish, respec-
tively). The polarographic system required recalibrating after
approximately 30 data sets, so we were unable to measure
the drift of the device.
In vivo data
A plot of tissue PO2 against time is depicted in Fig. 3A. The
baseline value of 11.2 kPa reflects the baseline FiO2 of 0.35
and is higher than resting values in similar in vivo studies that
used 0.21 as their baseline FiO2 [21]. This is an important
concept because arterial PO2 has a profound and incompletely
understood effect on tissue PO2. The tissue PO2 fell very
quickly after the aorta was cross-clamped, and it began to rise
again when tissue perfusion was re-established. Soon after the
animals breathed 100% nitrogen, the tissue PO2 fell sharply
and rose again when oxygen was reintroduced into the inspired
gas mixture. Fig. 3B shows the data presented by intervention.
For this graph, the mean values of the last three data points
before a change were taken to reflect that intervention.
Discussion
There is increasing interest in the use of tissue PO2 as a
monitor of critical illness [15,16,22–24]. The most favorable
tissue in which to record this variable has yet to be deter-
mined, and candidates include the gut [25], subdermis [26],
skeletal muscle [27], wound margins [11], brain [15], and
bladder mucosa [28]. We demonstrated that dynamic fluo-
rescence quenching is at least as accurate as the polaro-
graphic system for measuring PO2.
The optical device used in this experiment measures PO2
using the principle of dynamic fluorescence quenching. As a
triplet molecule, oxygen is able to quench efficiently the phos-
phorescence and fluorescence of certain luminophores, and
it is this concept that underlies the principle used by optical
systems such as ours to measure PO2. When an oxygen mol-
ecule collides with a fluorophore in its excited state, there is a
non-radiative transfer of energy that leads to a reduction in
the fluorescence displayed by the fluorophore. The PO2 value
in the medium that contains the fluorophore is inversely pro-
portional to the intensity of fluorescence exhibited. This rela-
tionship is described by the Stern–Volmer equation:
Figure 1
(A) Plot of fluorescence, polarographic and predicted partial oxygen
tension (PO2) against time. (B) Correlation plot of polarographic and
fluorescence measurement techniques. (C) Bland–Altman plot of
polarographic and fluorescence techniques demonstrating proportional
bias arising from one (or both) of the techniques.I0/I = 1 + k·PO2 (2)
where I0 is the fluorescence intensity recorded at zero oxygen
tension, I is the intensity at oxygen tension P, and k is the
Stern–Volmer constant. According to this equation, the rela-
tionship between PO2 and signal intensity is linear, but this
assumption is only valid for lower values of PO2 (below
approximately 20 kPa). For partial pressures greater than
20 kPa, it is necessary to employ a second-order polynomial
algorithm:
I0/I = 1 + k1(PO2) + k2(PO2)2 (3)
where I0 is the fluorescence intensity recorded at zero oxygen
tension, I is the intensity at oxygen tension P, k1 is the first
coefficient and k2 is the second coefficient. Sinaasappel and
lnce [29] pointed out that oxygen is 10% less soluble in
serum than in water [30], and thus recommended the use of
concentration rather than tension as a unit of measurement
for in vivo work. The solubility of oxygen in interstitial fluid (in
the tissue milieu) is not known, and it is uncertain whether it
differs from that of oxygen in water or serum. Even if it does, it
is improbable that the solubility would differ from one type of
tissue to the next because that would require a difference in
the composition of the extracellular fluid, which is unlikely.
Thus, the effect of any unmeasured differences in oxygen sol-
ubility would be (at most) to introduce a small systematic bias
into the data. The intensity of the fluorescence signal
increases as the PO2 decreases, and this is reflected by the
increasing accuracy of optical systems at low PO2 levels. This
feature of dynamic fluorescence quenching, coupled with the
fact that it does not consume oxygen in the measurement
process, makes it attractive for the detection and monitoring
of hypoxia.
According to the manufacturer, the accuracy of the fluores-
cence quenching technique is affected by the calibration pro-
cedure, the resolution (random noise), and deviations from
the Stern–Volmer relationship, which occur primarily at higher
PO2 values. It is reasonable to assume that this technique
would work in vivo, and our representative animal data,
although limited, suggest that this approach is feasible and
Available online http://ccforum.com/content/6/1/076
Figure 2
(A) Bland–Altman plot of fluorescence technique and predicted partial
oxygen tension (PO2), demonstrating close limits of agreement and no
systematic or proportional bias over the measurement range. (B)
Bland–Altman plot of polarographic technique and predicted PO2
demonstrating clear proportional bias, which corrects with logarithmic
transformation of the data (C).
Figure 3
Data are expressed as means ± SEM from three animals. (A) Plot of
skeletal muscle partial oxygen tension (PtO2) against time, showing
clear reduction in signal during both ischemic (cross clamp) and
hypoxic epochs. (B) PtO2 plotted by intervention. Significant
differences were found between PtO2 values for each group and the
baseline PtO2 value, and between each intervention group and the
group immediately preceding it.accurate, at least in skeletal muscle. Predictably, the tissue
PO2 dropped during both the period of presumed ischemia
(aortic cross-clamping) and hypoxia (FiO2 = 0.0), and we con-
clude from this that the fluorescence quenching method is
able to detect changes in a biologically plausible signal.
The technique of oxygen measurement described here is at
least as accurate as the accepted polarographic technique, is
cheaper and more wieldy, does not consume oxygen, and
may be combined with existing devices (such as a nasogas-
tric tube) more easily. We believe that this approach is a
useful addition to the available techniques and that it might
allow more widespread use of tissue PO2 measurement, both
as a marker of tissue integrity and an indicator of impending
pathology.  In vivo studies of fluorescence quenching PO2
measurement under different pathophysiologic conditions are
currently underway in our laboratory.
We believe our data illustrate an important concept in the
interpretation of method comparison studies. Reliance on the
correlation coefficient alone may lead to the erroneous con-
clusion that there is no difference between the techniques
[20]. Close correlation (with a high value for r2) merely identi-
fies a close relationship between two variables. The method
of Bland and Altman reveals differences between the two
techniques, and we believe that close limits of agreement
with a small overall bias should be characteristic features of a
dataset that leads to a conclusion of no difference between
the two methods under consideration. Our data revealed a
proportional bias in the standard technique, and we were
able to demonstrate this by comparing both techniques with
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